Johnson & Johnson General Corporate — Total Assets increased by 2.4% to $31.89B in Q3 2025 compared to the prior quarter.
An increase may indicate higher corporate cash reserves or centralized investments, while a decrease could signal capital deployment or asset divestiture.
This represents the total value of assets held at the corporate level that are not specifically allocated to individual...
Most large-cap conglomerates report similar unallocated corporate assets, often representing the company's central treasury and non-operational holdings.
jnj_segment_general_corporate_assets| Q1 '22 | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|
| Value | $39.19B | $33.92B | $34.52B | $38.71B | $49.83B | $31.16B | $31.89B |
| QoQ Change | — | -13.5% | +1.8% | +12.1% | +28.7% | -37.5% | +2.4% |
| YoY Change | — | — | +1.8% | +12.1% | — | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.